RxDoctor Payments Data

Douglas Adams, MD

Orthopaedic Surgery · Colorado Springs, CONPI 1760689707

Payments from drug & device makers

$14,017in general payments, 2019–2025

Across 166 payments — averaging $84.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$12K
  • Medtronic$1K
  • Integra Lifesciences Corporation$256
  • Carbofix Orthopedics Inc$223
  • Miach Orthopaedics, Inc.$132
  • Alliance Medical$123
  • plus $268 from 5 others

What the payments were for

  • Consulting fees$1,84013%
  • Travel & lodging$2,53618%
  • Food & beverage$9,64169%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker130$11,978
Medtronic(2 entities)24$1,038
Integra Lifesciences Corporation2$256
Carbofix Orthopedics Inc1$223
Miach Orthopaedics, Inc.1$132
Alliance Medical1$123
Johnson & Johnson(2 entities)2$103
Gemini Mountain Medical, LLC1$92
Ferring Pharmaceuticals Inc.2$31
Orthofix Medical, Inc.1$27
Paladin Technology Solutions1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,017 in reported general payments places this provider in the 65th percentile of 383 orthopaedic surgery providers in Colorado.

See all orthopaedic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$128,720
Medicare patients
196
Services billed
1,836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban20$5,632
Cyclobenzaprine Hcl49$832
Gabapentin65$488
Oxycodone Hcl41$318
Ibuprofen14$165
Naproxen25$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$103$5,63220 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 383 orthopaedic surgery providers in Colorado.

Other orthopaedic surgery in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →